Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
065/2022 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8
Framkvæmdarákvörðun framkvæmdastjórnarinnar (ESB) 2021/1289 frá 2. ágúst 2021 um frestun að því er varðar lokadag samþykkis fyrir dasómeti til notkunar í sæfivörur í vöruflokki 8
Durchführungsbeschluss (EU) 2021/1289 der Kommission vom 2. August 2021 zur Verschiebung des Ablaufs der Genehmigung von Dazomet zur Verwendung in Biozidprodukten der Produktart 8
Kommisjonens gjennomføringsbeslutning (EU) 2021/1289 av 2. august 2021 om utsettelse av utløpsdatoen for godkjenningen av dazomet til bruk i biocidprodukter av type 8
History
19.03.2022
Adopted JCD confirmed entry into force date
19.03.2022
Compliance date in the EEA
18.03.2022
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
28.10.2021
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
02.08.2021
Adoption date in the EU
23.08.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.